HCV-IN-37 structure
|
Common Name | HCV-IN-37 | ||
---|---|---|---|---|
CAS Number | 2425804-98-2 | Molecular Weight | 515.64 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C31H35F2N5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HCV-IN-37HCV-IN-37 (Compound 3d) is a potent inhibitor of HCV. HCV-IN-37 is orally available and long-lasting in rat plasma after oral administration to rats by a single dose of 15 mg/kg. The high potency of active derivative HCV-IN-37 is primarily driven by the inhibitory effect on the virus entry stage[1]. |
Name | HCV-IN-37 |
---|
Description | HCV-IN-37 (Compound 3d) is a potent inhibitor of HCV. HCV-IN-37 is orally available and long-lasting in rat plasma after oral administration to rats by a single dose of 15 mg/kg. The high potency of active derivative HCV-IN-37 is primarily driven by the inhibitory effect on the virus entry stage[1]. |
---|---|
Related Catalog | |
Target |
EC50: 0.005 ± 0.005 μM (HCV)[1] |
References |
Molecular Formula | C31H35F2N5 |
---|---|
Molecular Weight | 515.64 |